Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine

Vaccine

Volumn 15, Issue 3, 1997, Pages 295-300

  Halperin, Scott A ^a   Barreto, Luis ^b   Eastwood, Brian J ^c   Medd, Lorna ^e   Guasparini, Roland ^e   Mills, Elaine ^d  

^a IWK HEALTH CENTRE   (Canada)

^b Division of Pathology   (Canada)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d MCGILL UNIVERSITY   (Canada)

^e NONE

Author keywords

acellular pertussis vaccine; combination vaccines; conjugate Haemophilus influenzae B vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG EFFICACY; DRUG SAFETY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TETANUS; VACCINATION;

ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FEMALE; HAEMOPHILUS VACCINES; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; VACCINES, COMBINED; VACCINES, SYNTHETIC;

EID: 0031044628     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00177-6     Document Type: Article

References (37)

1. Centers for Disease Control. Summary of notifiable diseases, United States, 1991. Morbid. Mortal. Wkly Rep. 1991 40, 35-36, 57-63
2. Varughese, P. Incidence of pertussis in Canada. Can. Med. Assoc. J. 1985, 132, 1041-1042
3. Cherry, J.D., Brunell, P.A., Golden, G.S. and Karzon, D.T. Report of the Task Force on pertussis and pertussis immunization - 1988. Pediatrics 1988, 81, 939-984
4. Aoyama, T., Murase, Y., Kato, M., Iwai, H. and Iwata, T. Efficacy and immunogenicity of acellular pertussis vaccine by manufacturer and patient age. Am. J. Dis. Child. 1989, 143, 655-659
5. Mortimer, E.A.Jr, Kimura, M., Cherry, J.D. et al. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. Am. J. Dis. Child. 1990, 144, 899-904
6. Centers for Disease Control. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use - supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP). Morbid. Mortal. Wkly Rep. 1992, 41(RR-1), 1-10
7. Centers for Disease Control. Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series; update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbid. Mortal. Wkly Rep. 1992, 41(No. RR-15), 1-5
8. Committee on Infectious Diseases Acellular pertussis vaccines: recommendations for use as the fourth and fifth doses. Pediatrics 1992, 90, 121-123
9. Edwards, K.M. Acellular pertussis vaccines - a solution to the pertussis problem?. J. Infect. Dis. 1993, 168, 15-20
10. Halperin, S.A., Barreto, L, Eastwood, B.J., Law, B. and Roberts, E.A. Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities. Arch. Pediatr. Adolesc. Med. 1994, 148, 1220-1224
11. Edwards, K.M., Bradley, R.B., Decker, M.D. et al. Evaluation of a new highly purified pertussis vaccine in infants and children. J. infect. Dis. 1989, 160, 832-837
12. Blumberg, D.A., Mink, C.M., Cherry, J.D. et al. Comparison of acellular and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants. J. Pediatr. 1991, 119, 194-204
13. Halperin, S.A., Mills, E., Barreto, L, Pim, C. and Eastwood, B.J. Acellular pertussis vaccine as a booster dose for 17 to 19 month old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age. Pediatr. Infect. Dis. 1995, 14, 792-797
14. Edwards, K.M., Meade, B.D., Decker, M.D. et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995, 96, 548-557
15. Decker, M.D., Edwards, K.M., Steinhoff, M.C. et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 1995, 96, 557-566
16. Englund, J.A., Glezen, W.P. and Barreto, L. Controlled study of a new five-component acellular pertussis vaccine in adults and young children. J. Infect. Dis. 1992, 166, 1436-1441
17. Englund, J.A., Decker, M.D., Edwards, K.M., Pichichero, M.E., Steinhoff, M.C. and Anderson, E.L. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. Pediatrics 1994, 93, 37-43
18. Ad Hoc Group for the Study of Pertussis Vaccines: Placebo-controlled trial of two acellular pertussis vaccines in Sweden-protective efficacy and adverse events. Lancet 1988, 1, 955-960
19. Trollfors, B., Taranger, J., Lagergård, T. et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 1995, 333, 1045-1050
20. Marwick, C. Acellular pertussis vaccine hailed for infants. J. Am. Med. ASSOC. 1995, 274, 446-447
21. King, G.E. and Hadler, S.C. Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious. Pediatr. Infect. Dis. J. 1994, 13, 394-407
22. Edwards, K.M. and Decker, M.D. Combination vaccines: hopes and challenges. Pediatr. Infect. Dis. J. 1994, 13, 345-347
23. Baker, J.D., Halperin, S.A., Edwards, K., Miller, B., Decker, M. and Stephens, D. Antibody response to Bordetella pertussis antigens after immunization with American and Canadian whole-cell vaccines. J. Pediatr. 1992, 121, 523-527
24. Halperin, S.A., Eastwood, B.J. and Langley, J.M. Immune responses to pertussis vaccines concurrently administered with viral vaccines. Ann. NY Acad. Sci. 1995, 754, 89-96
25. Halperin, S.A., Langley, J.M. and Eastwood, B.J. Effect of inactivated poliovirus vaccine on the antibody response to Bordetella pertussis antigens when combined with diphtheria-pertussis-tetanus vaccine. Clin. Infect. Dis. 1996, 22, 59-62
26. Ferreccio, C., Clemens, J., Avendano, A. et al. The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoid-pertussis vaccine at two, four, and six months of age. Pediatr. Infect. Dis. J. 1991, 10, 761-771
27. Clemens, J., Ferreccio, C., Levine, M. et al. Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. J. Am. Med. Assoc. 1992, 267, 673-678
28. Halperin, S.A., Eastwood, B.J., Barreto, L. et al. Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants two to six months old. Scand. J. Infect: Dis. 1995, 27, 279-287
29. Manclark, C.R., Meade, B.D. and Burstyn, D.G. In: Serological response to Bordetella pertussis. Manual of Clinical Laboratory Immunology, 3rd ed (Eds Rose, N.R., Friedman, H. and Fahey, J.L.). American Society for Microbiology, Washington, DC, 1986. pp. 388-394
30. Gillenius, P., Jäätmaa, E., Askelöf, P., Granström, M. and Tiru, M. The standardization of an assay for pertussis toxin and antitoxin in microplate culture of Chinese hamster ovary cells. J. Biol. Stand. 1984, 13, 61-66
31. Armitage, P.and Berry, G. Statistical Methods in Medical Research, 2nd Edn. Blackwell Scientific Publications, Oxford, 1987. pp. 118-119
32. Breslow, N.E. and Day, N.E. Statistical Methods in Cancer Research, Vol. II, The Design and Analysis of Cohort Studies. International Agency for Research on Cancer, Lyon, France, 1987, pp. 108-113
33. Scheifele, D., Barreto, L., Meekison, W. et al. Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid?. Can. Med. Assoc. J. 1993, 149, 1105-1116
34. Gold, R., Scheifele, D., Barreto, L. et al. Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr. Infect. Dis. J. 1994, 13, 348-355
35. Shinefield, H., Black, S., Ray, P. et al. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobials and Chemotherapy. Safety of combined acellular pertussis vaccine in infants [Abstract No. G72]. American Society for Microbiology, Washington, DC, 1995, p. 171
36. Greenberg, D.P., Wong, V.K., Partridge, S., Howe, B.J., Jing, J. and Ward, J.I. In: Program and Abstracts of the 35th Inter-science Conference on Antimicrobials and Chemotherapy. Evaluation of a new combination vaccine that incorporates diphtheria-tetanus-acellular pertussis, hepatitis b, and Haemophilus influenzae type b conjugate vaccines [Abstract No. G70]. American Society for Microbiology, Washington, DC, 1995, p. 170
37. Eskola, J., Olander, R.M., Litmanen, L, Saarinen, L, Bogaerts, H. and Kayhty, H. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobials and Chemotherapy. HIB antibody response after two doses of combined DTPa-Hib conjugate vaccines compared to separate injections [Abstract No. G11]. American Society for Microbiology, Washington, DC, 1995, p. 160